Esophageal Cancer

Posted on by
Reply

One of the least studied cancers in humans, although a deadly type of esophageal cancer. The survival rate five years is full of people with cancer, only 16% of people in the United States and 10% of people with esophageal cancer in Europe. Esophageal cancer is the sixth leading cause of cancer in the world, and the eighth most common cancer.

The incidence of esophageal cancer in the geographical areas of the world is very different. Northeast Iran has the largest incidence of cervical cancer (206 and 262 per 100,000 person-years for men and women) have been reported worldwide. The risk of esophageal cancer is 20 times larger than the population of China in West Africa. Cancer Cases in Taiwan is 9 per 100,000 in 2006, Jiangsu, China, the incidence was 30 per 100,000 in 1990-1992. The large difference in the incidence of demonstrates that environmental factors pathogenesis of this disease.

In addition, the geographical area, a number of factors which contribute to esophageal cancer. Alcohol increases risk of disease from cancer of the esophagus. The more a person drinks, the greater the risk of the disease. Similarly, the cancer-smoking. Nitrosamines in tobacco causes contact with the wall of the pharynx and induce cancer in the cancer cell growth. Because alcohol use increases the risk of cancer and duration of smoking, higher consumption of tobacco per day. If alcohol users are also consumers of tobacco the risk of esophageal cancer increased by 20 to 50 times greater than non-smoking and non-alcoholic drinkers were compared.

Some diseases, conditions and medical procedures can cause cancer of the esophagus such as achalasia, the bulge of the esophagus, caustic lesions of the esophagus, and exposes the history of radiation therapy to the mediastinum. Socio-economic status may be the development of esophageal cancer. Low-income black Americans in the media was 8.0 times more often from cancer than those with higher-income groups.

How can we prevent esophageal cancer? The researchers recommend consumption of foods rich in fiber such as whole grains, fruits and vegetables on a regular basis. Study of the effects of green tea suggests that are regularly used in this cancer. Of course, smoking and excessive consumption of alcoholic beverages in all cases, the risk of developing this disease.

Proteins in Yeast Replication

Posted on by
Reply

Some of the mutants exhibit increased replication, recombination, thereby to combine these processes. Saccharomyces pombe certain alleles of DNA polymerase ?-DNA ligase and RAD2 + a mutator phenotype. The increase mutations mutants indicate that the corresponding wild-type protein modifications and rearrangements of the genome will lead inhibition after recombination in S phase, recombination is mutated in cells arrested in S phase MCM increased. In addition, mutants of S. pombe RAD2 be synthesized with lethal mutants, RAD50 and rhp51 rhp54 (homologous S. pombe RAD50, RAD51 and Rad54 gene), suggesting that recombination has become necessary, an Okazaki fragment reduced metabolites. Association of reduced increase in replication is also dependent recombination in S. cerevisiae prokaryotes and described, suggesting that this is a common feature of the S-phase

A number of mutants to show that the recombination phase error S. In S. pombe mutant RAD50 S phase compared with wild-type cells and are sensitive to HU delayed. Vertebrate cells, the inactivation of recombination proteins Rad51 and Mre11 result in DNA breakage and cell killing. These and other observations have led to the suggestion that recombination proteins is a normal part of the S phase of eukaryotic genomes with a protective immunity. Thus, the replication fork start and stop can be used as part of normal phase S occurring in eukaryotes, prokaryotes are described.

There are several fork Duplikationprozess implications, depending on the cause. Ideally, the fork is a protected structure and the components are assembled during the arrest. The fork lose structural integrity when the protection is not in this case, the folding and the generation of breaks in DNA ends likely to be fatal to the cell when it is corrected. Recombination is a mechanism of DNA replication fork can restore, far from breaking. Although the origin of replication depends on the best recombinant prokaryotes, in which it appears that such a process the work in eukaryotes. Origin of the yeast S. cerevisiae replication by degradation (PDO), can be induced, in hundreds of kilobases of the replica of chromosomal DNA breakage. S. pombe, in the absence of telomeric sequences by telomerase in the cells, probably replicate recombination mechanism.

It is important that the recombination induced by replication is expected that, irrespective of the origin of replication and protein. Consequently, the mechanical connections, and recombination in the S-phase, which is likely important to wait for the stability of the entire genome. Cells with replication forks stable when treated HU. If the structure by the fork arrest of the fork, the synthesis of HU the media should be maintained. If the fork structure can not be maintained, to decompose in the fork, in the manufacture of double-stranded DNA. Recombination is a mechanism of DNA breaks and the formation of stalled replication forks can be restored.

Auriculotherapy And Phytotherapy Used in Cancer Treatment

Posted on by
Reply

Auriculotherapy or ear acupuncture is a therapy based on the piling of needles in the ear. Its historical roots date back to classical antiquity of Mediterranean people, Hippocrates, the father of Western medicine, described the scarifications of the posterior ear against sexual impotence and treat sciatica. And again, Galen described the therapeutic use of scarifications in some diseases of the ear. Auriculotherapy is based on the principles of conventional medicine and Western uses of specific points of the ear that correspond to somatotopic areas distant parts of the body, such as the stomach, the muscles of the spine, and so on. By insertion of needles or other stimuli can cause reflexes that induce stimulation of neurogenic type in organs and tissues of the human body. In this discipline the therapeutic concept of the disease remains the same medicine, the only thing that changes is the way of doing therapy, then gastritis or gallstones are the same disease described in the treaties of Medicine officer, have nothing to do with particular beliefs or philosophies, and the same condition is given the same treatment.

The acupoint used to treat nausea in all these diseases is always the same and does not vary according to personality the patient’s eating habits, etc. Scientific research in this field is developing rapidly, although at the moment auriculotherapy in cancer patients has proved especially useful for pain treatment.

Phytotherapy deserves a separate mention because herbal medicine is the discipline that comes closest to the natural conventional medicine as it is based of course on the use of chemicals present in plants, with organic farming activities. Besides, just think that 30 – 40% of conventional drugs derived from herbal substances. Herbal medicine is the medical discipline so using medicinal plants and derivatives in prevention and treatment of diseases, in relation to the pharmacological properties of chemical constituents present in the plant, or better in the preparation used. It does not follow diagnostic or therapeutic methods different from those of scientific medicine. The medicinal plant, so it can simply be considered, a container of chemicals, sometimes isolated and used as such in therapy, in other cases the source of raw material for the production of drugs or as a basis for the production of herbal medicines themselves. Herbal medicine is a discipline particularly promising for the cure cancer, both as a preventive measure or as a complementary therapy to chemo and radiotherapy or surgery. It is used as an immunostimulant, for treatment of gastrointestinal disorders and radiodermatitis and to combat certain symptoms such as fatigue, depression, constipation, etc.

There are also many studies that confirm the pre-clinical anticancer activities of substances present of many plants. The substances of plant origin may also be toxic, causing serious interactions with pharmaceutical drugs taken concurrently, or be responsible for allergic reactions. For these reasons, suitable extracts must always be used, quality controlled, standardized active ingredients, purified from useless or dangerous, and used only with medical prescription. For example, cancer patients often use honey and aloe smoothies (presented as a miracle cure for cancer!), not knowing that just some substances present in the plant cut the effectiveness of Chemotherapy.

Please consult an oncologist or more than one before you begin a cancer treatment.

The author’s mom died of cancer when she was just 40 years old.
Since then, the author has always been reading and researching about orthodox and alternative cures for cancer.
Read more about how to cure cancer gently!

General Symptoms That May Indicate Cancer

Posted on by
Reply

oday there are in excess of 200 different recognised types of cancer, each with its own definition, symptoms and treatments. There are however a number of general cancer symptoms which are more likely to occur with common forms of the disease. These symptoms do not necessarily indicate cancer, as they can often be associated with other common ailments but if any of the following are present, it is always worth speaking to a doctor.

The disease is best managed if symptoms are identified early and the type and severity of the cancer is diagnosed as soon as possible. Common signs of cancer include unexplainable weight loss, lumps, changes in the shape and size of moles, unusual bowel habits, persistent breathlessness or a cough and bleeding which is abnormal. These cancer symptoms will be explored in more detail below.

Weight loss which is not the result of exercise dieting of stress may indicate cancer, particularly if it occurs over short space of time. Such weight loss may be accompanied by general pain, sickness and fatigue, all of which could be cancer.

Identifying lumps requires you to know your own body as they can appear anywhere. Lumps are caused by all manner of reasons but if one appears and is consistently getting larger or is painful then it is wise to speak to a medical professional.

Changes in the shape, size and colour of moles can, in some instances be skin cancer symptoms, as can itchy, crusty or bleeding moles. Once again these symptoms may indicate melanomas and should be seen by a healthcare professional.

Unusual bowl habits may be symptoms of bowel cancer. Such symptoms would be changes in the colour of stools, going more often, having the feeling that you have not emptied your bowels after sittings and abdominal pain. Once again these could be signs of many different conditions but it is important to rule out bowel cancer.

Persistent coughing, hoarseness and breathlessness once again can be caused by many different conditions, even common colds. It is if the symptoms persist for a period of more than a few weeks and if you notice blood in your phlegm (not always present) that it is worth visiting the doctors.

Abnormal bleeding could occur after sex, during urination, vomiting or coughing. Ultimately any persistent and unusual bleeding from anywhere in your body is worth having checked out just to get peace of mind.

If you think you have any cancer symptoms you should always have them checked by your doctor. Normally they will refer you to a specialist who will advise the best course of action after a more detailed examination of your symptoms.

Cancer Immunotherapy

Posted on by
Reply

Effective in immunotherapy against cancer deaths due to tumor cells, cytotoxic T lymphocytes (CTL), regression of tumor, and patient survival results. Malignant tumors are often characterized by a high proliferative capacity, local and systemic invasiveness, lethality, and these qualities have made surgical resection, radiation, and ineffective for many patients with cancer chemotherapy. Tumors are also filled with antigens which generate suppresses substantial immune recognition and infiltration of immune cells, tumor cells, but the microwave conditions (for example, production of immunosuppressive cytokines), “anti-cancer activity. Potential of the innate immune system separately and systematically to react to local and metastatic lesions to prevent and to the memory of recurrence of the tumor, the development of cancer immunotherapy program, re-inspired by the answers to the study. major challenge is to develop methods of treatment, the exact immune system stimulation, and continuous support reactions of the immune system of tumor cells (mostly CTLs) to provide patients with the tumors are completely removed

The existing approaches to immunotherapy are two main types of vaccines against cancer, and combined with adoptive parents of the transfer of T cell vaccines for cancer antigens of the vaccine site tumors and tumor regression, based on a number of events in dendritic cells (DC) to treat the cause. Antigen detection and treatment is inherent in the control of machines that are activated when a strong feature of modified tumor antigens, transplantation antigens (MHC), and assuming the risk of signs of pathogens (such as bacterial DNA and lipopolysaccharide) promoted the expression of specific molecules and cytokines. Activated DC, then move to the lymphatic system interacting with the T cells with antigenic peptides, and MHC vessel immunostimulatory cytokines, this signal and the antigen-specific T-cell differentiation, and expansion of the type diffusion, and the ability of T-cell response induced by an active PED is, and extrapolating the vaccines of cancer, depending on the various factors: the nature of the antigen (endogenous exogenous) microenvironment of the DC reality antigen measurement of DC activation and the number of developing countries, differentiation, and growth stimulation of CTL. Contrary to the vaccines, adoptive transfer of older pass T-cells and antigen in the delivery, the agents activation of T cells autologous or allogeneic T cells that are changed in an ex vivo cultures and judges chose the cancer-specific antigens.

Although cancer vaccines and adoptive parents to transfer T-cell-specific CTL response to tumor-associated antigens and cause tumor regression in the subgroup of cancer patients, these treatments did not grant a pension to survive, proliferate. Clinical trials of vaccines against cancer is to provide a variety of methods of an antigen, including most of the tumor antigen, and lysates were irradiated tumor cells from DC or a patient with a tumor antigen pulsed ex vivo cultures. Auxiliaries and the Toll-like receptors (TLRs) agonists is often used in vaccines for the symbol (factors associated with the infectious micro-environments) to improve the supply, and maturation of dendritic cells mixed with effector responses. Limitations of current methods of antigen presentation short and brief stimulation of the immune system in vivo half-lives (in tissues and immune cells) and DC therapy or transplantation, T cells, damage to, high-speed cell viability and cell function is not to manage the transfer. To separate the alignment and to reduce the rapid loss of bioavailability and bioactivity of current therapies is likely to limit the effectiveness of DC activation and CTL-tumor effect of a passing attack. Intuitively, induction of anti-tumor CTL activity requires organization-resistant tumor regression and the stress is removed large tumors.

The development and application of immunologically active biomaterials, which influence the development, and T-cells and to regulate the response of antigens and the tumor is a major role in modern Immunotechnology investigation, comprising two approaches to play the regulation of biomaterials and continuous functioning of the immune system, immune system stimulation and to monitor the modified drug, and cells in a niche market in three dimensions. You can manage a wide range of particle systems, biopolymers, biological, pharmacokinetics and localization of proteins and nucleic acids has been developed, and we aim to discuss the important antigens and adjuvants to develop their skills in immunological targeting of DC. In addition, bio-, alternative methods for the manipulation of the cells ex-vivo (as in the DC-based vaccines, the transmission and reception of T-cells) is used to regulate the biofunctional formed by a three-dimensional matrix of micro-environment and the different cells of the immune system and the transaction T and the DC-situ activation.

We also stress the use of these systems and niche markets in the Premier DC and T-cell responses to tumors in animal models, and their views of the clinical effect of immunotherapy of cancer. Sources and inspiration for biomaterials Biomaterials other combinations of natural or synthetic components, and the definition should interact with biological systems. Biomaterials have developed in the past behavior of such cells in tissue regeneration, skin grafts, or to replace tissue function [eg, stents and prostheses] Traditionally, these materials have been made to increase the help minimize the host’s immune and inflammatory reactions because they can destructive influence. However, understanding the immune-regulation and increase the development of materials science and surgery has been created, the possibility of using bio-immunologically active immunotherapy of cancer. This section deals with the sources and raw materials for the production of bio-systems and the inspiration for his design as a means of drug delivery and synthetic extracellular matrix to control cellular processes.

Raw materials

Nature provides many sources of structural proteins and polysaccharides of plants and animals can be adjusted by the immune-active biomaterials. Natural materials such as collagen, the connective tissue proteins in animals, crustacean exoskeleton polysaccharide chitosan and alginate polysaccharides of algae and gels for drug delivery devices, or in deposits formed in isolated cell transplantation. These materials have been clinically used for cosmetic and wound care with established biocompatibility. Furthermore, let set to regulate the concentrations of molecular weight and crosslinking density of collagen, chitosan, and alginate gels are macromolecules with degradation stiffness, and the functional groups affects the development of the kinetic release bound biomolecules, or an immunostimulant for a drug or a predetermined strength and activation of cells which interact with the matrix material.

Biodegradable devices may also be prepared by a variety of synthetic polymers and are frequently used as carriers of medicines. Polyglycolide (PGA), polylactides (PLA) and copolymers of polylactide-co-glycolide (PLG), which degrades by hydrolysis of natural products, lactic acid and glycolic acid, are widely used in clinic biodegradable threads, and is usually in particulate form, is released from the systems prepared as biomolecules. Polyanhydrides are second class of biodegradable materials as carriers for drugs, such as platelets used in the clinical delivery of chemotherapy resection of glioblastoma site for research and vaccine carriers. In addition, particles arranged in liposomes (phospholipids), and block copolymers with hydrophobic and hydrophilic regions micellar vesicles or carriers such as proteins and nucleic acids housing to protect against degradation in vivo, and the release thereof.

Controlled delivery and cell targeting

Technical solutions are needed for therapeutic biomolecules for specific therapy areas controlled kinetics, which have guided the development of biomaterials and vans. Molecular therapies are based on prevention and treatment of many diseases in humans, but its use is limited to short in vivo half-life by limiting their bioavailability and tissue cells. Thus, in some cases be used a number of authorities systemic therapeutic molecules for therapeutic stimulation, but this increases the non-specific cells or tissue to cause severe side effects and lead-time of exposure and advantages of the treatment.

Biomaterials are now equipped with physical properties such as disintegration, and a specific surface properties, and the encapsulated bioactive molecules from degradation in vivo, so that they do not, and the release kinetics of the control target cells in vivo. To effectively combat drugs (immune-stimulating cytokines, for example), researchers are developing advanced micro-and nano-particles of specific surface molecules (eg antibodies) to help recognize and bind to specific cells immunologically. The size and surface characteristics of these particles are also the systems, will be suitable, location of body tissues and the particles in liquids are classified in the chambers (lymphoid tissues, for example) is guided. The physical media used to define not only to serve and protect the degradation of proteins and nucleic acids in vivo, but they can also determine the specific degradation properties of bioactive his office in certain tissues or delivery of a regular cell internalization on cellular channel.

Synthetic ECM

The natural matrix (ECM) is a structure and function, is an inspiration in the development and implementation of systems of three-dimensional biomaterials in different micro-environments that chemical signals and mechanical properties of the cells seem to produce on the spot. Space contains connective tissue protein (collagen and laminin ECM), gels, polysaccharides such as glycosaminoglycans and heparin sulfate.

ECM provides a variety of ligands, providing support for cell adhesion and cell attachment, cell controls the communication / migration, masked, and a wide range of growth factors, cell – both the local repository. ECM components and enzymes responsible for reducing the population cells produced in response to local irritation (e.g. infection), the ECM remodeling and cell re-allocation signal, which may be homeostasis in cells and the matrix reachieved. Thus, the ECM to regulate the interaction of cells dynamic process, and the system capacity can be converted to biomaterials.

The three-dimensional biomaterial constructs were developed to provide the necessary support structures, such as synthetic ECM stem cell delivery, and long-term deposits in a controlled presentation of bioactive molecules that regulate how and when the micro-controlled environments, niche markets, the functioning of cells. Porosity and degradation of these materials, presence of cells and the host cell infiltration can be controlled or optimized using the treatment of the cells. Ligands for the adhesion surface of the biomaterial is a spatial distribution of the cells and cell-cell communications controller is formed by the synapses of the immune system.

Basics About Kidney Cancer

Posted on by
Reply

Kidney cancer is cancer that are not common. Compromise, only about 2% of cancer cases diagnosed each year. There are several types of cancer are known to affect the kidneys. The most common form of kidney cancer is renal cell carcinoma, such as kidney or renal adenocarcinoma known renal cell carcinoma. It is considered endangered if September 10 renal cell carcinoma. Other types of kidney cancers are transitional cell carcinoma, renal sarcoma, and Wilms’ tumor. Wilm’s tumor was common in children with kidney disease. And, like most cancers, if kidney cancer is malignant, it has spread to nearby lymph nodes and the rest of the body.

The specific risk factors that predispose an individual is not fully known renal cell carcinoma. Several factors are taken into account. One is smoking. Smoking is to increase the risk of cancer because of its toxic byproducts such as tar and nicotine. Obesity is a factor to be considered, because they cause increases in blood pressure issues. This addition lead to kidney damage, because they are directly filtered and the waste rock in the blood. Genetics may also be a factor in cancer, and so on. Can people in the von Hippel-Lindau (VHL) syndrome and the risk of kidney cancer. VHL tumor is a kind of genetic disorders that can be grown in different parts of the body. If a smoker is at risk of developing kidney cancer and it or not, it is important that he should stop smoking, because smoking is associated with many diseases. The same goes for obesity, and thus maintain a healthy body weight is necessary.

There are no obvious signs and symptoms of kidney cancer, and unfortunately, in most cases, kidney cancer at a later stage of the disease were tested. There are times when it is detected at an early stage, but a generally random orientation. The most common symptoms that may occur in the flank or back pain, blood in urine and abdominal mass. But the most common signs and symptoms of other diseases, the diagnosis is still very difficult.

Used to diagnose kidney cancer similar to other types of cancer. X-ray, ultrasound imaging, computed tomography and magnetic resonance imaging are just a few tools are used for cancer. It IVP every time used as a diagnostic tool. Tests of blood and urine tests may also be used to improve the diagnostic tool. The fine needle aspiration was performed after a preliminary assessment is made. This leads to the fact if the cancer is actually present or not.

And, like most cancers, the cancer is diagnosed with stones in 4 steps. The scene is at an early stage of cancer. Size of a tumor, only about 7 cm or less. Metastases has not yet begun, and the average tumor size of about the same as a tennis ball. Step II is above the tumor, about 8-9 cm or more and still metastases Mo. Phase III is a piece of bone in the lymph nodes, surrounding tissue or nearby blood vessels. And the last stage, stage IV tumors can metastasize through the surrounding tissue, lymphatic system and / or surrounding organs. This step is the most commonly observed in renal cancer. Although there are treatment options for kidney cancer in time, it is important that the second statement should be continued. This is done to confirm the diagnosis of the disease, proper treatment can be started with the patient.

Replication Defects

Posted on by
Reply

The recent completion of the Saccharomyces pombe genome revealed a large number of fission yeast genes coding for the participation in human cancers. Interestingly, many of the genes with known or suspected acts of DNA in yeast. The current data suggest that different pathways control eukaryotic DNA replication in genetic instability and cancer susceptibility can be stopped. Thus reducing the release of CDK activity triggering the origin, changes in the time of ignition, loss of control on the order of S phase and M-phase, but also the inability to limit the replication of the cell cycle Both mechanisms are all able changes in chromosome structure and gene activity causes. Moreover, the weakness in the checkpoint response to replication is blocked, and the inability to respond adequately, stalled replication forks, also contribute to genome instability. Reach, in fact, or result in the loss of genetic information to an inappropriate expression of proto-oncogenes or tumor suppressor loss of function.

If the normal time at home to shoot is interrupted, the cells are sensitive to dissolved cell cycle progression. It can be a single-gauze replication origin of the cell cycle or a delayed ignition under conditions that prevent the normally fire trigger. Saccharomyces cerevisiae and therapeutic anti-tumor agent adozelesin change of the basic model origin of replication, replication fork active chromosomes in mammalian cells cations also the time of replication in a particular order. Conversely, an uncontrolled cell proliferation, the replication of the release time. The mutant was found checkpoints and S. pombe and human cancers. Thus, the disturbances in the timing and coordination of genome replication pathwaytoward instability.

The cells increases the number of overlapping mechanisms for DNA control limit, and once the cell cycle. S. The pombe, this is by setting the CDK kinase activity, phosphorylation, and reaches the destruction of Cdc18 and phosphorylation of STET. In human cells, which is for the Cdc6 Cdc18 negatively by CDK-regulated in the phosphorylation, suggesting that the regulation of the human helps to prevent re-replication to Cdc6. CDK-MCM proteins other things, that at least some organisms. Associated There are several examples of CDK activity with the introduction of cancer.

The overexpression of certain replication proteins can act as CDT1 to the development of tumors in mammals. In addition, many of the replication proteins that are overexpressed in cancer cells. Human Cdc7 (equivalent of the S. pombe HSK1 kinase), an overexpression of certain tumor cells. In addition, the human proteins, the MCM (or overexpression) in dividing cells expressed and not detectable sleeping cells. A significant influence of these results is that the presence of MCM proteins in the cells a sensitive diagnostic cell proliferation provides. MCM proteins, the cells were restarted and the rigidity of the cell cycle to MCM proteins in cancer cells and tumor cells were observed. The MCM further activate transcription of oncogenes. It is interesting, suggesting people BM28/CDCL1 (homologous MCM2), mapped on chromosome categories with chronic myeloid leukemia associated with that BM28/CDCL1 candidate oncogene. Damage tolerance and repair mechanisms are also important for genomic instability. S. pombe is Rqh1 required to restore the replication blocks. Human cells have at least five Rqh1 reaction, which are associated with three cancer susceptibility syndromes. These mutations Bloom syndrome, BLM, WRN mutations in Werner syndrome results and RECQL4 mutations in Rothmund-Thomson syndrome caused. Hyperrecombination cancer susceptibility and usually both Bloom and Werner syndromes. Recombination is not appropriate because the loss of other functions to produce the S-phase extension or deletion of genetic information, as in S. cerevisiae. Polymerase slippage may contribute to the development of triplet-repeat sequences of a number of diseases such as Huntington’s disease.

The checkpoint genes are important guardians of genomic stability. Mutations of the ATM cell cycle ataxia telangiectasia with mutations of the cell cycle and Cds1 (also known as Chk2) is connected, is the group of patients with Li-Fraumeni syndrome. In addition, overexpressed Rad17 (a checkpoint Rad protein) in various human tumors. The corresponding proteins in S. pombe that (Rad3, Rad17, and Cds1) in the cell block in response are involved in replication. S. pombe Rad4/Cut5 protein XRCC1 play a role in cells of the control point at which the BRCT subject matter is also in the tumor suppressor BRCA1 and human DNA repair protein. Thus, mutations that disrupt the functioning part of the replication checkpoint is also the tendency of cancer. Can lead to genomic instability cancer chromosomal error, the S phase of the process of DNA caused. The S. pombe proteins required for a process to activate the closed until ESO1 sisterchromatids mitosis are subject to change. A portion of the protein is gay liquor in the DNA polymerase ESO1 ? (Rad30) having a deficiency Xeroderma pigmentosum variant by the tendency of skin cancer is characterized. Moreover, the lead axis normal human premature sister chromatid separation changes and swelling of the cell when overexpressed. Cohesin Rad21 expression is downregulated in some tumors. In addition, HP1 reduced or metastatic breast cancer cell invasive. Counterpart of S. pombe HP1 Is that Rad21 recruits SWI6 centromeres and other regions of heterochromatin. By second cohesin SMC1 subunit phosphorylated shown that for the position of the control and the S-phase required in human cells. Besides the direct connection connects the role of chromatin structure in maintaining genome stability.

Operation of various experimental systems in recent years has shown striking similarities in basic cellular processes in eukaryotes. In addition, the synergy studies of DNA replication, recombination and chromosome structure important information to other DNA are integrated into cellular processes. DNA studies of S. pombe and place in other model systems, proteins and pathways, to identify a framework and label information about genes important for the process industry (synthetic lethality) offer is an important source for understanding how mutations in other genes have similar phenotypes such as sensitivity can cause cancer. Some recent studies support the efficacy of yeast mutants with defects in chromosome instability in models for the cell reactions to drugs in the treatment of cancer. This simple eukaryote at the forefront of basic knowledge of normal and abnormal cell division continued.

Feedback Regulation

Posted on by
Reply

Exquisite sensitivity of the prostate are androgenic steroids is gaining ground in the development of systemic therapy for prostate cancer over 70 years available. Sustainable strategic approach focuses on prevention a way that is unique in the use of androgen deprivation therapy and antiandrogen for advanced prostate cancer, Cancer Cell overview. Treatments continue to serve the standard of care, but, unfortunately, is not anti-androgen therapy improves, and new techniques are needed. With the advent of targeted therapies antiandrogens for cancer continued to be based on a combination of treatments can be developed, including those that focus on common oncogenic signaling in development.

Prostate cancer in a particularly difficult situation for a variety of genetic changes in the context of this disease. A well-known molecular target for treating prostate cancer is a PI3K-ACP. A recent study of 218 prostate cancer found that 42% of primary tumors and metastases 100% of genomic abnormalities in this pathway fed.

Characteristic genetic changes in direction, PTEN, which is indicated for the mutated and / or loss of heterozygosity of 15% show a local and 30% in metastatic prostate cancer. PI3K inhibitors are small molecules of ACP-signaling has been developed and clinically tested. Although early results of clinical trials are necessary, the therapeutic activity of inhibitors of PI3K-ACP as agents simple in advanced cancer of the prostate usually moderate. This is a great effort to the rational-ACP PI3K inhibitors in combination therapy protocols.

In the recent issue of Cancer Cell, the same report recognizes the reciprocal feedback regulation between AR and PTEN signaling loss/PI3K-AKT prostate cancer. Effective use of PB-Cre; Ptenlox / Lox mouse model and carefully annotated human samples of prostate cancer tissues, two research groups, to promote understanding of the regulation for growth and innovative offers security signaling of cancer cells and has an extension, some reasons for using specific combinations to treat advanced prostate cancer. A similar approach is the loss of PTEN activity in motion a series of molecular events that link the network with two major signaling used to control the growth, security, and differentiation of prostatic epithelial cells do. The activation of PI3K-AKT signaling pathway PTEN mutation in PB-Cre; Ptenlox / Lox mice leads to the repression of AR signaling.

Transcriptome analysis reveals a significant overlap between genes upstream and downstream regulated between men intact in PTEN / mice and castrated wild type mice and also showed that loss of PTEN is associated with decreased AR signaling a lack of PTEN in prostate tumors of man. According to previous studies that loss of PTEN activity and activation of PI3K-AKT signaling that the seeds of castrate levels of androgen-independent growth of prostate cancer in the creation of the genetic program. Both pharmacological and genetic methods for a variety of mechanisms related to the output to remove Ar PI3K-ACT, but signs of inhibition of MEK signaling Ar, and that this inhibition of inhibition of HER-kinase. In re-expression of PTEN approach could avoid the loss of PTEN androgen responsive genes EGR1 up-regulation C-Jun expression and periods of transcription and catalytic subunit of Polycomb repressive complex 2, EZH2. The loss of PTEN can lead to repression of AR signaling at two levels: upstream prevention of MAPK stimulated by HER-kinase and repression / subversion of the AR-mediated transcription in the transcript enhanced sequences and histone methyltransferases. Examining the response PBCre castration; Ptenlox / Lox mice, the mice PB-myc and androgen-refractory prostate cancer cells and analysis of two knockout mutant of PB-Cre is Ptenlox / Lox , Arlox / Y, the mouse and human samples of prostate cancer, led to the surprising finding that another important ar-castration or loss increases the phosphorylation of the CPA.

An important to note that these two experimental identification of the other solitary negative feedback signal is thePB-Cre, Ptenlox / loxmodel and androgen-sensitive lines of human prostate cancer cells, the signal is ar-stimulated, FKBP5-mediated activation of the phosphatase activity PHLPP ACP ACP is inhibited. Based on these results support the hypothesis that both groups of castrated prostate mode (or down-Ar), greater loss of PTEN dependence / AKTsignaling of PI3K. Successfully this hypothesis in vivo, scientists showed synchronously Carver and his colleagues found that the combination of BEZ235 (dual PI3K and mTOR inhibitor) and castration leads to a strong decrease in tumor volume is not the difference the impact of LNCaP xenografts a treaty and an almost complete pathological response to the PB-Cre, Ptenlox / lox model, Mulholland, and his colleagues have shown that rapamycin (mTOR inhibitors) treatment of castration PB-Cre; Ptenlox / lox Arlox / Y, the prostate cancer in mice harboring significantly reduced and an increase in tumor burden compared to the castration alone. And negative feedback, Ar, and PTEN signaling network loss/PI3K-AKT implemented is fascinating on many levels. However, analysis of the gene does not prevent the PI3K-ACP-independent, PTEN loss of routes set up a monitoring-regulates the expression of EGR1, c-Jun and EZH2, which is your loss of PTEN and androgen signaling / PI3K-AKT.

It is known that the AR signaling for growth and differentiation of prostate epithelial cells to spread. The accuracy and coordination of morphogenesis of androgen regulation of prostate growth and differentiation depends largely on the work involved in AR target genes that are modulated in different periods.

A recent study showed that the TMPRSS2-ERG gene product of fusion can be androgenic signaling in prostate cancer cells through several mechanisms, such as binding AR target genes and induction of expression of EZH2, which may interfere with the prostate to remove cell differentiation. In addition, under certain conditions, the ACP-PI3K signaling pathways and provide better Ar-Ar genes, such as p21WAF/CIP associated with the growth of androgen-independent prostate cancer. In light of new information on this mechanistic framework, the detection of negative feedback between the AR and PI3K-AKT signaling network, it may be possible to better identify and draw the signaling pathways more and translation andidentifyadditional have periods and modifiers of chromatin, attached to the target AR gene-specific functions related to androgen-dependent growth of the prostate and / or differentiation, and growth of the androgen independent prostate cancer. Ruthless selection process in which cancer cells develop resistance to all kinds of research on anti-cancer drugs and clinical oncologistswith presents a difficult task. Their mutual discovery of an important negative feedback and the Ar loss/PI3K-AKT PTEN signaling in cancer of the prostate.